First-in-human Data Validate Potential of Elekta's MR-linac to Revolutionize Radiation Oncology
Go back to First-in-human Data Validate Potential of Elekta's MR-linac to Revolutionize Radiation Oncology| Elekta B Shs Unsponsored ADR representing B Shares (AMEX: EKTAY) | Delayed: 5.76 -0.07 (1.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.83 | 52 Week High | $9.94 | |||
| Open | $5.80 | 52 Week Low | $6.79 | |||
| Day High | $5.80 | P/E | N/A | |||
| Day Low | $5.76 | EPS | $0.00 | |||
| Volume | 14,673 | |||||
